Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

Researchers at Rice University have developed a new method for performing chemical reactions using water instead of toxic ...

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

Asia Pharma Expo to showcase cutting-edge advancements in mfg: Our Bureau, Mumbai Tuesday, February 11, 2025, 15:40 Hrs [IST] The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, ...

The Palisades Fire burned down Monica and Ben Odell's home and laboratory, where the husband-and-wife pair were working on a technology aimed at shaking up the food industry. "It has just been a lot ...

New projects and agreements covered pharmaceuticals, health foods, biotechnology and electrical industries announced ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

The fifth meeting of the Higher Committee for Integrated Industrial Partnership for Sustainable Economic Development held in ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...